The drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

Medically reviewed by Elizabeth Barnes, RDN GLP-1 drugs like Ozempic and Wegovy delay gastric emptying, which means the food ...

The agency and Novo Nordisk, which makes Ozempic, said Monday that they had learned about "several hundred units" of the drug ...

Ozempic (semaglutide ... drugs if you have a condition called multiple endocrine neoplasia syndrome type 2 (MEN 2). This condition can raise your risk of thyroid cancer. If you use Ozempic ...

If you or someone in your family has had MTC or MEN 2, tell your doctor. In this case, they’ll likely recommend a treatment other than Ozempic for your condition. If you’ve had an allergic ...

Semaglutide medications like Ozempic and Wegovy have exploded in popularity ... Women were more likely to have this outcome, with twice the risk of men. The researchers were not surprised by ...

Study authors found a slightly higher risk of hair loss, especially in women, with semaglutide (Ozempic) compared to ...

It's unclear whether women respond to Ozempic differently than men. Other GLP-1 receptor agonists like Ozempic have been shown to cause side effects twice as much in women as in men. In one study ...

April 14 (Reuters) - Danish drugmaker Novo Nordisk NOVOb.CO said on Monday several hundred counterfeit units of its diabetes drug Ozempic were being distributed outside its authorized supply chain ...

Study authors found a slightly higher risk of hair loss, especially in women, with semaglutide (Ozempic) compared to bupropion-naltrexone. “The risk increase was under 1% for men and just over 2 ...